20 May 2008: PreViser Corporation (http://www.previser.com), a Washington State-based provider of patented oral disease and risk assessment technology to the dental profession, announced today the finalization of a licensing agreement with Oral Health Innovations (OHI) Ltd (www.previser.co.uk) of Birmingham, England to market PreViser technology to dentists within the United Kingdom and the Republic of Ireland.

OHI Ltd is a joint venture with the University of Birmingham. Following on from a successful pilot, OHI will launch PreViser at a Denplan sponsored seminar for Denplan Excel accredited practitioners in June 2008. Discussions are also underway with a number of NHS Primary Care Trusts on how the technology can be used as a best practice tool within NHS dentistry.

Iain Chapple, Professor of Periodontoogy and Consultant in Restorative Dentistry, who runs an NHS referral centre serving approximately six million patients, acts as adviser to OHI Ltd. Prof. Chapple commented, “PreViser is unique in its web-based approach to risk and disease scoring and has a scientific evidence base behind its efficacy. However, one of its biggest benefits is the immediate and personalized biofeedback it offers to patients. We all know that successful periodontal therapy is founded on patient education and compliance with home care regimes. PreViser is a most innovative tool that motivates patients to take personal responsibility for their own oral health.

“In addition to the obvious patient and practitioner benefits, PreViser allows oral healthcare funders to focus their resources towards those that need it most and provides a platform from which to deliver truly preventative oral care in a cost effective manner.

“As a teacher, it is exciting to be able to utilize the system, which is provided free of charge to Dental Education establishments for educational purposes. The interactive nature of the platform is something dental students actively engage in and learn from. I would encourage every dental school to take advantage of this technology.”

PreViser Corporation provides web-enabled diagnostic decision support tools for dentists, dental hygienists and therapists. The PreViser Oral Health Information SuiteTM enables quick, accurate, reproducible and objective diagnosis and analysis of oral disease risk in an easy-to-understand format for the professional and the patient.

A percentage of profits of OHI Ltd will be contributed to the Oral & Dental Research Trust of the UK and to a research fellowship at the University of Birmingham.

For further information contact: Oral Health Innovations Ltd: Liz Chapple, liz@previser.co.uk
PreViser Corporation: Carl Loeb, 360-941-4715, info@previser.com